(1R,5S)-8-乙酰基-8-氮杂双环[3.2.1]辛烷-3-酮 | 56880-02-5

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 托烷生物碱
• 中文名称: (1R,5S)-8-乙酰基-8-氮杂双环[3.2.1]辛烷-3-酮
• 英文名称: 8-acetyl-8-azabicyclo[3.2.1 ]octan-3-one
• 英文别名: 8-acetyl-8-azabicyclo[3.2.1]octan-3-one；8-acetyl-nortropan-3-one；8-Acetyl-nortropan-3-on；N-Acetyl-nortropinon；8-Azabicyclo[3.2.1]octan-3-one, 8-acetyl-
• CAS: 56880-02-5
• 化学式: C₉H₁₃NO₂
• 分子量: 167.208
• InChiKey: RKTPOXAAOHCGDQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  37.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (1R,5S)-8-乙酰基-8-氮杂双环[3.2.1]辛烷-3-酮 在 一水合肼 、 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 反应 0.08h， 生成 1-(3-phenyl-4,5,11-triazatricyclo[6.2.1 .0^*2,6^*]undeca-2(6),3-dien-11-yl)-ethanone
  参考文献：
  名称：

  Substituted 4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridines, Their Use as Medicament, and Pharmaceutical Preparations Comprising Them

  摘要：

  这项发明涉及到式(I)的取代4,5,6,7-四氢-1H-吡唑并[4,3-c]吡啶类化合物，它们作为药物的用途，以及包含它们的药物制剂。式(I)的化合物作用于TASK-1钾通道。这些化合物特别适用于治疗或预防心房心律失常，例如心房颤动（AF）或心房扑动。

  公开号：

  US20140330009A1
• 作为产物：
  描述：

  托品酮 在 1-氯乙基氯甲酸酯 作用下， 以 1,2-二氯乙烷 为溶剂， 反应 11.0h， 生成 (1R,5S)-8-乙酰基-8-氮杂双环[3.2.1]辛烷-3-酮
  参考文献：
  名称：

  A modified palladium catalysed reductive amination procedure

  摘要：

  New, extended applications of a modified palladium catalysed reductive amination procedure are described; a mechanistic hypothesis alternative to the common imine pathway is proposed. This versatile method advances the usual reductive amination processes in terms of yield and shows high stereoselectivity whether applied to constrained carbonyl compounds. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(02)00530-6

文献信息

• [EN] COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS<br/>[FR] COMPOSÉS ET LEUR UTILISATION POUR LE TRAITEMENT DE TROUBLES ASSOCIÉS AU RÉCEPTEUR H3 DE L'HISTAMINE
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2013027001A1

  公开（公告）日：2013-02-28

  The present invention provides compounds of formula (1) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, R18, R19, R20, m, n, p, q, Q1, Q2, Q3, Q4, Q5, Q6, X1, X2, X3, X4, A1 and L1, are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

  本发明提供了式（1）的化合物及其药学上可接受的盐，其中R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、R12、R13、R14、R15、R16、R17、R18、R19、R20、m、n、p、q、Q1、Q2、Q3、Q4、Q5、Q6、X1、X2、X3、X4、A1和L1如规范中所定义，其制备方法，含有它们的药物组合物以及它们在治疗中的用途。
• METHODS FOR ONE-POT N-DEMETHYLATION/N-ACYLATION OF MORPHINE AND TROPANE ALKALOIDS
  申请人：Carroll Robert James

  公开号：US20090005565A1

  公开（公告）日：2009-01-01

  The present invention provides a method for the N-demethylation and/or N-acylation of an N-methylated heterocycle such as morphine alkaloids or tropane alkaloids. The method comprises reacting the heterocycle with an acylating agent in the presence of a metal catalyst.

  本发明提供了一种用于对N-甲基杂环化合物（如吗啡生物碱或曲梨生物碱）进行N-去甲基化和/或N-酰化的方法。该方法包括在金属催化剂存在下将杂环化合物与酰化剂反应。
• [EN] SUBSTITUTED 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINES, THEIR USE AS MEDICAMENT, AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM<br/>[FR] 4,5,6,7-TÉTRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINES SUBSTITUÉES, LEUR UTILISATION EN TANT QUE MÉDICAMENT ET PRÉPARATIONS PHARMACEUTIQUES LES COMPRENANT
  申请人：SANOFI SA

  公开号：WO2013037415A1

  公开（公告）日：2013-03-21

  The invention relates to substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines of formula (I), their use as medicament, and pharmaceutical preparations comprising them. The compounds of formula (I) act on the TASK-1 potassium channel. The compounds are particularly suitable for the treatment or prevention of atrial arrhythmias, for example atrial fibrillation (AF) or atrial flutter.

  该发明涉及式(I)的取代4,5,6,7-四氢-1H-吡唑并[4,3-c]吡啶，它们作为药物的用途，以及包括它们的药物制剂。式(I)的化合物对TASK-1钾通道起作用。这些化合物特别适用于治疗或预防心房心律失常，例如心房颤动（AF）或心房扑动。
• [EN] SUBSTITUTED 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINES, THEIR USE AS MEDICAMENT, AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM<br/>[FR] 4,5,6,7-TÉTRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINES SUBSTITUÉES, LEUR UTILISATION COMME MÉDICAMENT, ET PRÉPARATIONS PHARMACEUTIQUES LES CONTENANT
  申请人：SANOFI SA

  公开号：WO2013037914A1

  公开（公告）日：2013-03-21

  The invention relates to substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines of formula (I), their use as medicament, and pharmaceutical preparations comprising them. The compounds of formula (I) act on the TASK-1 potassium channel. The compounds are suitable for the treatment or prevention of atrial arrhythmias, for example atrial fibrillation (AF) or atrial flutter.

  该发明涉及公式（I）的取代4,5,6,7-四氢-1H-吡唑并[4,3-c]吡啶，其用作药物以及包含它们的药物制剂。公式（I）的化合物对TASK-1钾通道起作用。这些化合物适用于治疗或预防心房心律失常，例如心房颤动（AF）或心房扑动。
• Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
  申请人：Bialy Laurent

  公开号：US09127001B2

  公开（公告）日：2015-09-08

  The invention relates to substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines of formula (I), their use as medicament, and pharmaceutical preparations comprising them. The compounds of formula (I) act on the TASK-1 potassium channel. The compounds are particularly suitable for the treatment or prevention of atrial arrhythmias, for example atrial fibrillation (AF) or atrial flutter.

  本发明涉及公式（I）的取代4,5,6,7-四氢-1H-吡唑并[4,3-c]吡啶，它们作为药物的用途，以及包含它们的制药制剂。公式（I）的化合物作用于TASK-1钾通道。这些化合物特别适用于治疗或预防心房心律失常，例如心房颤动（AF）或心房扑动。